Authors

Jin Q. Cheng

Document Type

Patent

Publication Date

May 2012

Patent Number

8178502

Abstract

The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat esophogeal adenocarcinoma by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.

Application Number

12/206,468

Assignees

University of South Florida

Filing Date

09/08/2008

Primary/U.S. Class

514/43

Share

COinS